Alveolar Rhabdomyosarcoma in a 69-Year-Old Woman Receiving Glucagon-Like Peptide-2 Therapy.

about

Alveolar Rhabdomyosarcoma in a 69-Year-Old Woman Receiving Glucagon-Like Peptide-2 Therapy.

Item

http://www.wikidata.org/entity/Q42416908

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Alveolar Rhabdomyosarcoma in a ...... ucagon-Like Peptide-2 Therapy.

@en

Alveolar Rhabdomyosarcoma in a ...... ucagon-Like Peptide-2 Therapy.

@nl

type

Item

label

Alveolar Rhabdomyosarcoma in a ...... ucagon-Like Peptide-2 Therapy.

@en

Alveolar Rhabdomyosarcoma in a ...... ucagon-Like Peptide-2 Therapy.

@nl

prefLabel

Alveolar Rhabdomyosarcoma in a ...... ucagon-Like Peptide-2 Therapy.

@en

Alveolar Rhabdomyosarcoma in a ...... ucagon-Like Peptide-2 Therapy.

@nl

P1476

Alveolar Rhabdomyosarcoma in a ...... ucagon-Like Peptide-2 Therapy.

@en

P2093

Jonathan B McHugh

http://www.w3.org/2001/XMLSchema#string

Laura E Zyczynski

http://www.w3.org/2001/XMLSchema#string

Scott M Schuetze

http://www.w3.org/2001/XMLSchema#string

Thomas E Gribbin

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2014

Rhabdomyosarcoma in adolescent and young adult patients: current perspectives.

Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma.

Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group

Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.

Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution.

Molecular biology of rhabdomyosarcoma.

Teduglutide: a review of its use in the treatment of patients with short bowel syndrome.

Syndrome-associated soft tissue tumours.

The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice.

P304

107479

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/107479

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280999242

http://www.w3.org/2001/XMLSchema#string

P698

26266067

http://www.w3.org/2001/XMLSchema#string

P932

4525456

http://www.w3.org/2001/XMLSchema#string